Oküler İnsertlere Genel Bir Bakış
Referanslar
Rathore K, Nema R. Review On Ocular Inserts. International Journal of PharmTech Research. 2009;1(2):164-9.
Polat HK, Sedat Ü. Development of Besifloxacin HCL Loaded Ocular In Situ Gels; In Vitro Characterization Study. Journal of Faculty of Pharmacy of Ankara University. 2023;47(1):39-50.doi: 10.33483/jfpau.1154051
Polat HK. Design of Metformin HCl and Moxifloxacin HCl Loaded Thermosensitive In Situ Gel. Journal of Research in Pharmacy. 2022;26(5).doi: 10.29228/jrp.215
Polat H. In Situ Gels Triggered By Temperature for Ocular Delivery Of Dexamethasone And Dexamethasone/SBE-Β-CD Complex. Journal of Research in Pharmacy. 2022;26(4):873-83.doi: 10.29228/jrp.186
Devhadrao N, Siddhaia M. Review On Ocular Insert Drug Delivery System. Journal of Drug Delivery and Therapeutics. 2018;8(5-s):115-21.doi: 10.22270/jddt.v8i5-s.1991
Kumari A, Sharma PK, Garg VK, et al. Ocular Inserts—Advancement in Therapy of Eye Diseases. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(3):291. doi: 10.4103/0110-5558.72419
Pawar PK, Katara R, Majumdar DK. Design and Evaluation Of Moxifloxacin Hydrochloride Ocular Insert. Acta Pharmaceutica. 2012;62(1):93-104.doi: 10.2478/v10007-012-0002-5
Urtti A. Challenges and Obstacles of Ocular Pharmacokinetics and Drug Delivery. Advanced Drug Delivery Reviews. 2006;58(11):1131-5.doi: 10.1016/j.addr.2006.07.027
Le Bourlais C, Acar L, Zia H, et al. Ophthalmic Drug Delivery Systems—Recent Advances. Progress in Retinal and Eye Research. 1998;17(1):33-58.doi: 10.1016/S1350-9462(97)00002-5
Polat HK, Kurt N, Aytekin E, et al. Novel Drug Delivery Systems to Improve the Treatment of Keratitis. Journal of Ocular Pharmacology and Therapeutics. 2022;38(6):376-95.doi: 10.1089/jop.2021.0127
Polat H, Ünal S, Aytekin E, et al. Ocular Drug Delivery Systems: Traditional Review. Literatür Eczacılık Bilimleri Dergisi. 2022;11(3).doi: 10.5336/pharmsci.2022-93906
Saettone MF. Solid Polymeric Inserts/Disks as Drug Delivery Devices. Boca Raton Biopharmaceutics of ocular drug delivery. 1st Edition.2019:61-79. doi: 10.1201/9780429284755
Tangri P, Khurana S. Basics of Ocular Drug Delivery Systems. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011;2(4):1541-52.
Sahane N, Banarjee S, Gaikwad D, et al. Ocular Inserts-A Review. Drug Invention Today 2010;2:57-64.
Hornof M, Weyenberg W, Ludwig A, et al. Mucoadhesive Ocular Insert Based on Thiolated Poly (Acrylic Acid): Development and In Vivo Evaluation in Humans. Journal of Controlled Release. 2003;89(3):419-28.doi: 10.1016/S0168-3659(03)00135-4
Zaffaroni A, Michaels AS, Theeuwes F. Osmotic Releasing Device Having A Plurality Of Release Rate Patterns. Google Patents; 1977.
Chien YW. Novel Drug Delivery Systems. Drugs and the pharmaceutical sciences. 1992;50.
Saettone MF, Salminen L. Ocular Inserts for Topical Delivery. Advanced Drug Delivery Reviews. 1995;16(1):95-106.doi: 10.1016/0169-409X(95)00014-X
Jervis L. A Summary of Recent Advances in Ocular Inserts and Implants. Journal of Bioequivalence & Bioavailability. 2017;9:320-3.
Brahmankar D, Jaiswal SB. Biopharmaceutics And Pharmacokinetics: A Treatise: Vallabh prakashan; 2005.
Sultana Y, Aqil M, Ali A. Ocular Inserts for Controlled Delivery of Pefloxacin Mesylate: Preparation and Evaluation. Acta Pharmaceutica. 2005;55(3):305-14.
Karthikeyan D, Bhowmick M, Pandey VP, et al. The Concept of Ocular Inserts as Drug Delivery Systems: An Overview. Asian Journal of Pharmaceutics (AJP). 2008;2(4).doi: 10.22377/ajp.v2i4.204
Khan A, Raza SN, Itoo A, et al. Ocular Inserts-A Novel Approach in Ocular Drug Delivery. Journal of Drug Delivery and Therapeutics. 2019;9(4):693-703.doi: 10.22270/jddt.v9i4.3207
Mitra AK, Anand BS, Duvvuri S. Drug Delivery to The Eye. Advances in Organ Biology. 2005;10:307-51.
Nayak BS, Patnaik SC, Sethy S, et al. Formulation Design and In Vitro-In Vivo Evaluation of Moxifloxacin Ophthalmic Insert. American Journal of Phytomedicine and Clinical Therapeutics. 2015;3:302-12.
Thakur RR, Kashiv M. Modern Delivery Systems for Ocular Drug Formulations: A Comparative Overview WRT Conventional Dosage Form. Int Journal of Pharmaceutical and Biomedical Sciences. 2011;2:8-18.
Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, et al. Novel Nanostructured Lipid Carrier-Based Inserts For Controlled Ocular Drug Delivery: Evaluation Of Corneal Bioavailability And Treatment Efficacy In Bacterial Keratitis. Expert opinion on drug delivery. 2015;12(11):1791-807.doi: 10.1517/17425247.2015.1059419
Grass GM, Cobby J, Makoid MC. Ocular Delivery of Pilocarpine from Erodible Matrices. Journal of Pharmaceutical Sciences. 1984;73(5):618-21.doi: 10.1002/jps.2600730509
Punch P, Slatter D, Costa N, et al. Investigation of Gelatin as A Possible Biodegradable Matrix for Sustained Delivery of Gentamicin To The Bovine Eye. Journal of Veterinary Pharmacology and Therapeutics. 1985;8(3):335-8.doi: 10.1111/j.1365-2885.1985.tb00965.x
Polat HK, Pehlivan SB, Özkul C, et al. Development of Besifloxacin HCl Loaded Nanofibrous Ocular Inserts For The Treatment of Bacterial Keratitis: In Vitro, Ex Vivo and In Vivo Evaluation. International Journal of Pharmaceutics. 2020;585:119552.doi: 10.1016/j.ijpharm.2020.119552
Attia M, Kassem M, Safwat S. In Vivo Performance of [3H] Dexamethasone Ophthalmic Film Delivery Systems in The Rabbit Eye. International Journal of Pharmaceutics. 1988;47(1-3):21-30.doi: 10.1016/0378-5173(88)90211-6
Rajput G, Sharma S, Chaudhury S. Review on Ophthalmic Inserts. International Journal of Pharma Professional’s Research. 2013;4(3):912-20.
Dwivedi P, Chand P, Gnanarajan G, et al. Review on Ocular Inserts. World Journal of Pharmaceutical Research. 2015;4:493-523.
